Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)

Bibliographic Details
Title:	Optimal duration of adjuvant chemotherapy for high-risk node-negative (N–) breast cancer patients: 6-year results of the prospective randomised multicentre phase III UNICANCER-PACS 05 trial (UCBG-0106)
Authors:	Kerbrat, Pierre, Desmoulins, Isabelle, Roca, Lise, Levy, Christelle, Lortholary, Alain, Marre, Alain, Delva, Rémy, Rios, Maria, Viens, Patrice, Brain, Étienne, Serin, Daniel, Edel, Magali, Debled, Marc, Campone, Mario, Mourret-Reynier, Marie-Ange, Bachelot, Thomas, Foucher-Goudier, Marie-Josèphe, Asselain, Bernard, Lemonnier, Jérôme, Martin, Anne-Laure, Roché, Henri
Source:	In European Journal of Cancer July 2017 79:166-175
Database:	ScienceDirect